Valley Medical Group News

The Valley Hospital Earns ‘Top Performer on Key Quality Measures®’ Recognition from The Joint Commission for Third Consecutive Year


RIDGEWOOD, NJ, NOVEMBER 17, 2015 — The Valley Hospital has been recognized as a 2014 Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in the United States.

Valley was recognized for exemplary clinical performance in the following areas: heart attack, heart failure, pneumonia, surgical care, stroke, and perinatal care. These recognitions are included in The Joint Commission’s 2015 annual report, “America’s Hospitals: Improving Quality and Safety.”

Valley is one of only 1,043 hospitals in the United States to achieve the 2014 Top Performer distinction. The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions, including heart attack, heart failure, pneumonia, surgical care, children’s asthma, inpatient psychiatric services, stroke, venous thromboembolism, perinatal care, immunization, tobacco treatment, and substance use.

This is the third consecutive year Valley has been recognized as a Top Performer in the areas of heart failure, heart attack, pneumonia, and surgical care.

To be a 2014 Top Performer, a hospital must have demonstrated a performance of 95 percent or higher on key accountability measures. A 95 percent score means a hospital provided an evidence-based practice 95 times out of 100 opportunities to provide the practice. Each accountability measure represents an evidence-based practice – for example, giving aspirin at arrival for heart attack patients, or giving antibiotics one hour before surgery.

“Delivering the right treatment in the right way at the right time is a cornerstone of high-quality health care. I commend the efforts of The Valley Hospital for their excellent performance on the use of evidence-based interventions,” said Mark R. Chassin, MD, FACP, MPP, MPH, president and CEO, The Joint Commission.